Long-term Outcome of Implantable Cardioverter/Defibrillator Lead Failure
This study compares outcomes of a recalled implantable cardioverter/defibrillator lead with a control lead in individuals in Iceland.
Related Articles
I Am Taking a GLP-1 Weight-Loss Medication—What Should I Know?
This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
Integrating Diet and Physical Activity When Prescribing GLP-1s—Lifestyle Factors Remain Crucial
This Clinical Insight reviews the lifestyle factors important for patients receiving glucagon-like peptide-1 and dual receptor agonists to manage weight.
The current issue of JAMA
Read the current issue. Keep up to date with the latest research, clinical reviews, and opinions.
The Path From Intracranial Pressure to Clinical Outcomes in Pediatric Traumatic Brain Injury
In the first publication on continuous intracranial pressure (ICP) monitoring in patients with traumatic brain injury (TBI) in 1965, Lundberg et al1 described periodic increases…
I Am Taking a GLP-1 Weight-Loss Medication—What Should I Know?
This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
I Am Taking a GLP-1 Weight-Loss Medication—What Should I Know?
This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
Integrating Diet and Physical Activity When Prescribing GLP-1s—Lifestyle Factors Remain Crucial
This Clinical Insight reviews the lifestyle factors important for patients receiving glucagon-like peptide-1 and dual receptor agonists to manage weight.
5 things doctors want you to know before you start taking a GLP-1
There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still matter, doctors say.
Cases, Hospitalization, and Mortality in COVID-19 and Influenza Among Veterans
This cohort study examines rates of positive tests, hospitalizations, and deaths for COVID-19 and influenza across the influenza seasons of 2022 to 2023, 2023 to…
Time to Progression to Proliferative Diabetic Retinopathy in Type 2 Diabetes
This prognostic study describes the development and validation of survival models using electronic health record data to predict the time to progression to proliferative diabetic…